I’m not a gambler, that’s why. Fundamentally CSLs earnings don’t stack up to its market cap, its been valued on earnings growth. I gather you don’t read any financial metrics. I’m not a trader. I’ve done well out of many other blue chips and generally I’m a value investor that compounds blue chips. CSL doesn’t fit my value metrics that’s all.
Very very dangerous randomly jumping in stocks based on trend. I’d personally buy Pfizer over CSL any day of the week. However I’m a value investor.
- Forums
- ASX - By Stock
- CSL
- CSL has more upside...
CSL has more upside..., page-21
-
- There are more pages in this discussion • 405 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$285.76 |
Change
-0.900(0.31%) |
Mkt cap ! $137.3B |
Open | High | Low | Value | Volume |
$285.50 | $285.86 | $282.18 | $63.29M | 222.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 62 | $285.71 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$285.76 | 29 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 51 | 285.710 |
1 | 9 | 285.680 |
2 | 35 | 285.660 |
2 | 53 | 285.640 |
2 | 54 | 285.620 |
Price($) | Vol. | No. |
---|---|---|
285.750 | 30 | 3 |
285.760 | 56 | 4 |
285.780 | 79 | 5 |
285.790 | 82 | 8 |
285.810 | 29 | 2 |
Last trade - 15.58pm 13/11/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online